VAXESS

May 23, 2013

Vaxess Announces $3.75M Series A Financing

Vaxess Technologies, Inc., an innovative life sciences company developing a novel silk protein-based vaccine stabilization technology, announced today that it has closed the first tranche of a $3.75 million Series A financing.

Vaxess Series A Press Release